Related by context. All words. (Click for frequent words.) 72 biosimilars 70 biogenerics 69 Biogenerics 66 Biosimilar 65 biosimilar 64 biogeneric 64 Cancer Vaccines 63 Lung Cancer Drug 62 Anti Infectives 61 generic biologic 61 Targeted Therapies 61 Generic Drug 61 Biologic Drugs 61 biologics 60 Rheumatoid Arthritis Drug 60 Monoclonal Antibodies 60 PharmaVitae Profile 60 Erectile Dysfunction Drug 59 Therapeutic Monoclonal Antibodies 59 generic biologics 59 Novartis Gleevec 59 Cancer Therapies 59 Phase III Trials 59 Investigational Drug 59 Personalised Medicine 59 Stakeholder Opinions 59 Pirfenidone 58 Novel Therapies 58 Psoriasis Drug 58 Migraine Drug 58 Arthritis Drug 58 biologics FOBs 58 Acne Drug 58 Biopharmaceutical Industry 58 Drug Pipeline 58 Emerging Therapies 57 Immunotherapies 57 Clofarabine 57 Investigational Drugs 57 Orphan Drugs 57 Therapeutic Targets 57 Antifungals 57 External Defibrillators 57 Glatiramer Acetate 57 Generics 57 Antibody Therapeutics 57 Protein Therapeutics 57 Inhaled Insulin 57 Pipeline Analysis 57 Genetic Testing 57 Cholesterol Lowering Drug 57 Comparative Effectiveness 57 generic biopharmaceuticals 57 Cladribine 57 Rotavirus Vaccine 57 Generic Version 57 Blood Pressure Drug 57 Regulatory Requirements 57 Influenza Vaccine 56 biogeneric drugs 56 Anemia Drug 56 Celgene Revlimid 56 Epilepsy Drug 56 Cholesterol Drug 56 PDUFA Prescription Drug 56 Gastrointestinal Disorders 56 Drug Eluting Stents 56 Vitro Diagnostic 56 PGx 56 Genetically Engineered Animals 56 Receives Positive Opinion 56 Breast Cancer Treatment 56 Drug Fails 56 Atypical Antipsychotics 56 Pharma Biotech 56 Prostate Cancer Vaccine 56 Hepatitis C Virus 56 Arthritis Drugs 56 Therapeutics Roundtable 56 Anti TNF 56 antidiabetics 56 Pfizer Lyrica 56 Dendreon Provenge 56 Partneringreview 56 Lupus Drug 56 AstraZeneca Symbicort 55 Advanced Colorectal Cancer 55 Generic Versions 55 Golimumab 55 Schizophrenia Drug 55 Drug Makers 55 Metabolic Disorder 55 cytotoxics 55 Hematological Malignancies 55 Statin Drugs 55 Cancer Stem Cells 55 Merck Januvia 55 Heartburn Drugs 55 Myelodysplastic Syndromes 55 Insulin Delivery Systems 55 Patient Enrollment 55 Orphan Diseases 55 Humira adalimumab 55 Generic Version Of 55 Tesamorelin 55 Novel Antibiotic 55 PROTONIX 55 Insulin Delivery 55 Cholesterol Drugs 55 Weight Loss Drug 55 Alemtuzumab 55 Pfizer Sutent 55 Asthma COPD 55 Generic Biologics 55 UCB Keppra 55 Personalized Medicine 55 FDA Orphan Drug 55 JAK Inhibitor 55 Gout Drug 55 Systemic Delivery 55 Phase 1b Clinical Trial 55 Ustekinumab 55 Accelerated Approval 54 Prolongs Survival 54 Postmarket 54 AstraZeneca Iressa 54 URCH Publishing 54 FDA Accepts 54 Ophthalmic Drug 54 Asthma Treatment 54 Erlotinib 54 Clinical Trial Enrollment 54 Dasatinib 54 Infertility Treatment 54 Bazedoxifene 54 Prostate Cancer Treatment 54 Therapeutic Approaches 54 AstraZeneca Brilinta 54 EvaluatePharma 54 Rosiglitazone 54 Osteoporosis Drug 54 RNAi Therapeutics 54 Therapeutic Proteins 54 Bevacizumab 54 Therapeutic Vaccines 54 Biomarker 54 HCV Protease Inhibitor 54 Submits NDA 54 FDA Approvals 54 Vitro Diagnostics Market 54 Pharmacogenomic 54 Analytical Tool 54 Renal Cell Carcinoma 54 Imported Drugs 54 Authorized Generic 54 Therapeutic Antibody 54 Drug Importation 54 Acute Heart Failure 54 Elagolix 54 Genes Involved 54 Hormone Therapy 54 Omnitrope 54 Drug Eluting Stent 54 Gastrointestinal Stromal Tumors 54 FDA Modernization Act 54 Hepatocellular Carcinoma 54 Genetically Modified Salmon 54 Unapproved Drugs 54 Therapeutic Antibodies 54 Cancer Treatments 54 Stem Cell Treatments 54 Elesclomol 54 Molecular Medicine Tri 54 Osteoporosis Treatment 54 Anticancer Agent 54 Muraglitazar 54 AstraZeneca Toprol 54 Dalbavancin 54 Therapeutic Potential 54 Chiral Technology 54 NDA Submission 54 Autoimmune Disease 54 PDUFA Date 54 Rheumatoid Arthritis Patients 54 Investigational Compound 54 Gene Expression Profiling 54 Milestone Payment 54 Regimens 53 Urinary Incontinence 53 HIV Integrase 53 Analgesics 53 Kidney Transplant Patients 53 Monoclonal Antibody 53 Lilly Cymbalta 53 Drug Approvals 53 Initiates Clinical 53 Key Milestones 53 Vascular Targeting Agents 53 ASCO GI 53 Shows Efficacy 53 Antibacterials 53 Excipients 53 Resubmission 53 Liver Toxicity 53 Biopharmaceutical Manufacturing 53 Anastrozole 53 Molecular Diagnostic 53 FDAAA 53 Darbepoetin Alfa 53 Investigational Agent 53 Mycamine 53 Interferon Alpha 53 Inhibitors 53 Pandemic Influenza Vaccines 53 biosimilar versions 53 Biotech Industry 53 Inhalation Solution 53 Receives Orphan Drug 53 Tumor Targeting 53 Civacir 53 Risperdal Zyprexa 53 Receives Orphan Drug Designation 53 Generic Protonix 53 Stent Placement 53 Injectable Drug 53 epoetin zeta 53 Neuropathic Pain 53 CNS Therapeutics 53 Intravenous Formulation 53 Transdermal Drug 53 Novel Protein 53 Sustained Release 53 VIVUS Qnexa 53 Antibiotic Resistance 53 Nivestim 53 Antiviral 53 Pazopanib 53 Biologics 53 Clinical Trial Results 53 Immunosuppressant 53 Diagnostic Tests 53 Phase 2a Trial 53 Cardiovascular Devices 53 ONGLYZA TM 53 Celebrex celecoxib 53 Biodegradable Polymers 53 biologic medicines 53 Nonprescription 53 Mycophenolate Mofetil 53 Companion Diagnostic 53 Clinical Trials 53 Drug Candidate 53 Electrophysiology Mapping 53 Seasonal Influenza Vaccine 53 DNA Sequencing 53 Estrogen Receptor 53 Vpriv 53 Synthetic Peptide 53 Pediatric Exclusivity 53 Drug Delivery 53 biologicals 53 Initiate Clinical Trial 53 Blood Thinning 53 Phase III Clinical Trials 53 Big Pharmas 53 Next Generation Biofuels 53 Phase IIb Clinical Trial 53 Positive Opinion 53 Optimer Pharma 53 Expanded Indication 53 Oral Insulin 53 INTUNIV TM 53 RNA Interference 53 FDA Advisory Panel 53 Survival Benefit 53 Anti Tumor 53 Dose Escalation 53 Fabry Disease 53 Aptamer 53 Carfilzomib 53 Generic Lovenox 53 Telaprevir 53 Avian Flu Vaccine 53 Clinical Trial Data 53 Extavia 53 Smooth Muscle 53 Fondaparinux 52 Contaminated Heparin 52 Amgen Nplate 52 Orphan Status 52 Anti Clotting Drug 52 biopharmaceuticals 52 Companion Diagnostics 52 BioCentury NewsMakers 52 Multiple Myeloma Patients 52 Treating Depression 52 Boceprevir 52 Recombinant Human 52 Genentech Avastin 52 Amgen Prolia 52 Cancer Biomarkers 52 Partnering Agreements 52 Avastin bevacizumab 52 Cervical Cancer Vaccine 52 Pertuzumab 52 Chronic Lymphocytic Leukemia 52 Oligonucleotides 52 Patient Recruitment 52 Captisol enabled 52 Benign Prostatic Hyperplasia 52 Sapacitabine 52 Disease Modifying 52 Romiplostim 52 Fixed Dose Combination 52 Present Preclinical Data 52 Tissue Sealants 52 Pulmonary Arterial Hypertension 52 Eribulin 52 Inflammatory Disease 52 Blood Thinner 52 Hematological Cancers 52 Evoltra 52 Radiopharmaceutical 52 Amlodipine Besylate 52 Vaccine Adjuvant 52 Amylin Byetta 52 Patient Outcomes 52 Schizophrenia Treatment 52 PrandiMet 52 molecular entities NMEs 52 Industrial Enzymes 52 Pharmaprojects 52 Orapred ODT 52 Combivir Kivexa 52 Hepatitis B Vaccine 52 Hormonal Contraceptives 52 Omapro 52 Process Validation 52 Immune Therapy 52 Renal Cancer 52 Mylan Receives Approval 52 Chemoprevention 52 Gene Silencing 52 Clinical Guideline 52 Interventional Cardiology Devices 52 Ozarelix 52 Pfizer inhaled insulin 52 Adjuvant Treatment 52 Glucophage XR 52 Letrozole 52 Injectable 52 Oncology Drug 52 Estrogen Therapy 52 Testosterone Patch 52 NMEs 52 Authorized Generics 52 Phase III Trial 52 Flu Vaccines 52 Aurora Kinase 52 Antiviral Drugs 52 Icatibant 52 Aliskiren 52 Antisense 52 Overactive Bladder 52 Receives Approvable Letter 52 Reimportation 52 Expedited Review 52 Licensing Agreements 52 Files IND 52 Novartis Galvus 52 First Patient Enrolled 52 Ebola Vaccine 52 Therapeutic Areas 52 BiTE Antibody 52 Meets Primary Endpoint 52 Biotechs 52 Firazyr 52 Maraviroc 52 Testosterone Gel 52 Cord Blood Banking 52 OSI Pharma 52 Vertex telaprevir 52 chemical entities NCEs 52 IND Filing 52 Molecular Diagnostic Test 52 Roche Xeloda 52 FDLI 52 Receptor Antagonists 52 FDA Critical Path 52 Initiates Phase III 52 predictive toxicology 52 Novel Approaches 52 ZEVALIN ® 52 Coronary Revascularization 52 Advanced Renal Cell 52 Oxymorphone ER 52 SmPC 51 ZEGERID Capsules 51 topical NSAID 51 Pafuramidine 51 Early Diagnosis 51 MicroRNA 51 Antiviral Therapeutics 51 Remicade infliximab 51 Pravastatin 51 Nymox NX 51 tubulin inhibitor 51 Vaccine Adjuvants 51 Rapidly Evolving 51 Blood Stem Cells 51 Focalin XR R 51 Hormone Refractory Prostate Cancer 51 vemurafenib 51 Chemokine Receptor 51 Carbapenems 51 glatiramer 51 Anticoagulant 51 Demonstrates Significant 51 Improves Survival 51 Taro Receives 51 HCl capsules 51 Certican 51 Gaucher Disease 51 Medical Device 51 Biotech Pharma 51 Antipsychotic Drug 51 Treanda 51 Pharmacokinetic Study 51 Hepatitis C Treatment 51 Genetic Tests 51 Cambridge Healthtech Institute 51 Cancer Immunotherapy 51 Data Exclusivity 51 Inc Therapeutic Competitors 51 ONGLYZA ™ 51 Colorectal Cancer Screening 51 Dyslipidemia 51 patent expiries 51 Demonstrates Potential 51 Pfizer Selzentry 51 Diverse Populations 51 Small Molecule 51 Antidepressant Drug 51 RNAi Therapeutic 51 Menopausal Hormone Therapy 51 Liprotamase 51 Ephedra Ban 51 Fluoroquinolones 51 MAbs 51 Tasigna nilotinib 51 Pandemic Vaccine 51 biologic drugs 51 Partnering Guide 51 SURFAXIN 51 SuperAntibody 51 Granted Orphan Drug 51 pancreatic enzyme replacement 51 Cardiometabolic 51 Molecular Diagnostics 51 Combination Therapy 51 entitled Formulary Advantages 51 Influenza Vaccines 51 Antimicrobials 51 M Enoxaparin 51 Diabetic Nephropathy 51 Oxaliplatin 51 Glucose Monitoring 51 Earns Milestone Payment 51 Canaccord Adams Hepatitis C 51 Prilosec heartburn drug 51 Anti Depressant 51 Bristol Myers Squibb Pravachol 51 Hycamtin 51 Therapeutic Competitors Companies 51 Phase 2a Clinical Trial 51 Dendritic Cells 51 OLEPTRO 51 Milnacipran 51 Phase III Clinical Trial 51 Inflammatory Diseases 51 Announces Tentative Approval 51 Adjuvant Breast Cancer 51 Velcade bortezomib 51 Pfizer Zoloft 51 GPhA 51 Uplyso 51 Successfully Completes Phase 51 topical dermatology 51 Metastatic Melanoma 51 BioElectronics Announces 51 Late Breaker 51 Lovaza TM 51 mAbs 51 Stronger Warnings 51 Arixtra 51 Previously Treated 51 Technological Advances 51 Smallpox Vaccine 51 Ambrisentan 51 Dr. Siegall 51 Placebo Effect 51 Improving Outcomes 51 Carbidopa Levodopa 51 Alternative Treatments 51 Breast Tumors 51 Nanoemulsion 51 MOVIPREP R 51 BioDelivery Sciences 51 Cancer Therapeutics 51 Demonstrates Potent 51 Embryonic Stem Cell 51 Trodusquemine MSI 51 Botulinum Toxin 51 Vion Pharmaceuticals 51 Treat Anemia 51 Data Suggest 51 Preclinical Models 51 Fluconazole 51 Counterfeit Drugs 51 Novel Mechanism 51 PrevOnco 51 Disease Modification 51 Disease Progression 51 Personalized Immunotherapy 51 Gastric Cancer 51 Orally Disintegrating 51 Doripenem 51 Hedgehog Pathway Inhibitor 51 Moxifloxacin 51 Antibacterial Drug 51 Anti infective 51 DNAwithPap TM Test 51 Vildagliptin 51 Insulins 51 Generic Drugs 51 Poster Presentations 51 Non Inferiority 51 Product Characteristics 51 Somatuline Autogel 51 Antifungal 51 Elestrin TM 51 Fast Track Status 51 IBPL 51 Anti Nausea 51 HCl Tablets 51 Xpert Flu 50 Embryonic Stem Cells 50 Contrast Agents 50 Arzerra 50 LibiGel ® 50 Japanese Encephalitis vaccine 50 Completes Patient Enrollment 50 Ticagrelor 50 Ketorolac 50 Anti CD# Antibody 50 Drug Discovery 50 Vicriviroc 50 biosimilar medicines 50 Tyrosine Kinase Inhibitor 50 Atelvia 50 Brovana 50 Vaccine Candidate 50 AstraZeneca Seroquel 50 Chronic Inflammation 50 Vitro Diagnostics 50 Insulin Resistance 50 ECTRIMS 50 RNA therapeutics 50 Wound Care Markets 50 Combo Therapy 50 oral taxane 50 Fortamet 50 Vandetanib 50 Bayer Onyx 50 Aromasin exemestane 50 Intellectual Property Portfolio 50 Darunavir 50 Clinically Tested 50 Marketing Authorisation Application 50 Combination Treatment 50 COX 2s 50 Allergic Rhinitis 50 Treatment Algorithm 50 Gleevec Glivec 50 Confirms Patent 50 Sumatriptan 50 Drug Applications ANDAs 50 Phase 2b Clinical Trial 50 Diabetic Foot Ulcer 50 proteasome inhibitors 50 etanercept Enbrel 50 Receives Complete Response 50 Deferiprone 50 Prescription Drugs 50 FDA Approves Generic 50 Thyroid Hormone 50 Anidulafungin 50 Antipsychotic Medications 50 Dosage Forms 50 Tablet Formulation 50 Efficacious 50 Specialty Pharmaceutical 50 Telavancin 50 anti CD# antibodies 50 Anthrax Vaccine 50 Beta Blocker 50 Kinase Inhibitor 50 Blood Glucose Meters 50 Peginterferon alfa 2b 50 Therapeutic Protein 50 Cethromycin 50 Biotech Crops 50 Hypercholesterolemia 50 Imitrex sumatriptan 50 Fulvestrant 50 Extended Release 50 Onsolis 50 Diagnosis Treatment 50 Nanobiotechnology 50 EXALGO 50 Dealmaking Profile 50 Files Investigational 50 Ixempra 50 ixabepilone 50 Tigecycline 50 CTLA4 Ig 50 Valsartan 50 Cholesterol Lowering Drugs 50 Single Dose 50 Global Generics 50 Calcium Acetate 50 Comparative Effectiveness Research 50 Regulatory Submissions 50 BAL# [002] 50 Zemplar 50 Slow Progression 50 Receives Tentative FDA 50 OMAPRO 50 Orexigen Contrave 50 Salmeterol 50 Genzyme Cerezyme 50 Transcatheter Valve 50 Therapeutic Agents 50 Drug Shows Promise 50 Olmesartan 50 Hydrochlorothiazide Tablets 50 Treatment Regimen 50 CERVARIX R 50 Preclinical Data 50 Theranostics 50 Genetically Engineered Salmon 50 Gamunex C 50 insulin analogues 50 Nasal Powder 50 AstraZeneca Nexium 50 User Fee Act 50 SUTENT ® 50 Eligard R 50 Retacrit 50 Eli Lilly Cymbalta 50 Lung Cancer Trial 50 Ocular Diseases 50 Raltegravir 50 Ion Channels 50 Novartis Gilenya 50 Sanvar 50 Anemia Drugs 50 5EU 50 Human Embryo 50 Sumatriptan Succinate 50 Pooled Analysis 50 PDE inhibitors 50 Avastin Herceptin 50 Investigational Treatment 50 Innovative Approaches 50 Espicom 50 Lansoprazole 50 Protein Kinase Inhibitors 50 SciBX 50 GlaxoSmithKline Imitrex 50 Eli Lilly Zyprexa 50 Sanofi Acomplia 50 Myocet 50 Entecavir 50 Oral Fingolimod 50 Low Dose 50 Bortezomib 50 Bucindolol 50 Novartis Lamisil 50 FDA Okays 50 Daptomycin 50 Universal Flu Vaccine 50 Romidepsin 50 Payer Forum 50 Forsteo 50 Lung Cancer Survival 50 selective estrogen receptor modulator 50 Fluticasone 50 MMR Vaccine 50 Imaging Technique 50 Fungal Infections 50 Ultracet R 50 Vectibix panitumumab 50 Analytical Methods 50 Pivotal Phase III 50 Cardiovascular Outcomes 50 Effient 50 macrolide antibiotics 50 Breast Cancer Metastasis 50 Benazepril Hydrochloride 50 Cold Medicines 50 Gene Expression Analysis 50 Chronic Lymphocytic Leukemia CLL 50 Elvitegravir 50 Epilepsy Drugs 50 CDP# 50 Roche Boniva 50 Targeted Therapy 50 Diet Pill 50 Gene Therapy Trial 50 Weight Loss Supplement 50 Allosteric 50 breast cancer pill Tykerb 50 Vfend 50 Vascular Targeting 50 Mabthera 50 Immunomedics Announces 50 Pivotal Trial 50 Lupus Nephritis 50 HDAC Inhibitor 50 Breast Cancer Recurrence 50 Biological Therapy 50 LEUKINE 50 Arixtra ® 50 Byetta LAR 49 Epidermal Growth Factor Receptor 49 Teva Provides Update 49 Rotavirus Vaccines 49 Glufosfamide 49 Kombiglyze XR 49 Noninvasive Prenatal 49 Postmenopausal Women 49 RIGScan CR 49 Mitigation Strategies 49 Upcoming Webinar 49 PROVIGIL 49 Terbinafine 49 monoclonal antibody therapeutics 49 Protein Biomarker 49 Improved Survival 49 Therapeutic Competitors companiesandmarkets.com adEgemonye 49 Signaling Pathway 49 Exemestane 49 Trobalt 49 Novel Therapeutics 49 Tygacil 49 biopharma 49 Glucosamine Chondroitin 49 clopidogrel bisulfate 49 Mipomersen 49 Ovarian Cancer Treatment 49 Biobanking 49 Anti Infective Drugs 49 Marketing Authorisation 49 GlaxoSmithKline Advair 49 Fexofenadine 49 BYETTA ® 49 Phase IIb Trial 49 PREVU x LT 49 Avila Therapeutics 49 Biomanufacturing 49 Patents Issued 49 Immunotherapeutic 49 Allegra fexofenadine 49 Healthcare Reform 49 GlaxoSmithKline Coreg 49 Calcium Supplements 49 Cannabinoid 49 glitazones 49 BioPharma 49 Wound Closure Devices 49 Aptivus R 49 Tesmilifene 49 ImClone Erbitux 49 Supplemental Biologics License Application 49 Preterm Labor 49 Cefazolin 49 Multidrug Resistant 49 Gammagard Liquid 49 Neural Stem Cells 49 Inflammatory Arthritis 49 Amgen Vectibix 49 PharmaVitae 49 Initiates Clinical Trial 49 generics 49 Warfarin Coumadin 49 Biopharmaceutical 49 Biogen NASDAQ BIIB 49 Breast Ultrasound 49 Innate Immunity 49 Pemetrexed 49 AstraZeneca Toprol XL 49 Genetic Variations 49 Rexahn Pharmaceuticals 49 Antimicrobial Coating 49 Collaborators Publish 49 Soy Isoflavones 49 Commonly Used 49 biologic therapeutics 49 Tamsulosin 49 Metabolic Endocrinology 49 NICE Recommends 49 Circulatory System Devices 49 Study Reinforces 49 Bivalirudin 49 Genzyme Myozyme 49 Pulmonary Arterial Hypertension PAH 49 Rofecoxib 49 proteasome inhibitor 49 HER2 Positive 49 ImmunoCellular Therapeutics 49 FDA Endocrinologic 49 Viagra Cialis Accutane 49 Temsirolimus 49 Resistant Hypertension 49 Therapeutic Vaccine 49 carbapenem 49 Elan Tysabri 49 Stem Cell Therapies 49 Antitumor Activity 49 SYCREST 49 Mirapexin 49 Avanafil 49 Guidelines Recommend 49 MEDA AB publ 49 Safinamide 49 pegylated interferons 49 Ltd Therapeutic Competitors 49 Ridaforolimus 49 Venous Thromboembolism 49 Hormone Replacement 49 IL# PE#QQR 49 BCR ABL inhibitors 49 Zegerid OTC 49 Diabetic Patients 49 Critical Path Initiative 49 Cancidas 49 ERYtech 49 Orphan Drug 49 Randomized Phase III 49 Stem Cell Treatment 49 Vulnerable Plaque 49 CNS Disorders 49 Mircera 49 Metabolic Profiling 49 Upcoming Presentations 49 darbepoetin alfa Aranesp 49 Lung Flute ® 49 Radiation Dose 49 Pivotal Clinical Trial 49 Interferon Alfa 49 Interferons 49 Surgical Procedures 49 patent expiry 49 Piperacillin 49 Tentative Approval 49 donepezil hydrochloride 49 Ezetimibe 49 FOLOTYN ® 49 Medication Errors 49 SCIB1 49 Kinase Inhibitors 49 Cell Therapies 49 Idenix Pharmaceuticals 49 Treatment Approaches 49 Metabolomics 49 Genedata Biologics 49 Silodosin 49 Lubiprostone 49 Genetic Discrimination 49 Oral Mucositis 49 Accountable Care 49 Therapeutic Competitors 49 Ramelteon 49 Cancer Vaccine 49 Presents Preclinical Data 49 Antidepressant Use 49 Severe Sepsis 49 Febuxostat 49 Brain Tumor Therapy 49 Reduced Risk 49 Orencia 49 Protein Interaction 49 Silicone Breast Implant 49 Structural Changes 49 Gets FDA Clearance 49 Chronic Constipation 49 biologics FOB 49 Patients Treated With 49 Significantly Improved 49 Stem Cell Debate 49 Pre Eclampsia 49 PLAVIX ® 49 Autoimmune Diseases 49 Pfizer Zyvox 49 Neoadjuvant Chemotherapy 49 Ipilimumab 49 Deforolimus 49 Artificial Pancreas 49 TOPROL XL 49 Phase 2b Study 49 Bladder Cancer 49 PREVU x 49 Biogen Tysabri 49 Initiates Enrollment 49 LEVADEX ™ 49 ACEON R perindopril erbumine 49 Orphan Designation 49 IND Application 49 Fracture Risk 49 Antibody Discovery 49 Levocetirizine 49 Stakeholder Insight 49 Novel Treatments 49 Milestone Payments 49 Mammalian Cell Culture 49 Replagal 49 Abacavir Sulfate 49 Actonel risedronate 49 Sanofi Aventis Taxotere 49 Eloxatin ® 49 Xarelto rivaroxaban 49 Casodex 49 blood thinner Xarelto 49 Treatment Resistant 49 mg Tablets 49 Onglyza 49 Nasdaq HGSI 49 Pharmacogenetics 49 Heart Stents 49 J.P. Morgan Healthcare 49 RECOTHROM R 49 Zenpep 49 TNF alpha inhibitors 49 Rivaroxaban 49 Salix Pharma 49 Shingles Vaccine 49 bio similars 49 Urokinase 49 Glaxo Advair 49 orphan medicinal 49 Indaflex 49 Long Term Efficacy 49 Detailed Product 49 Galantamine 49 Entocort 49 Akorn Inc 49 Biologic 49 pharmerging markets 49 Hormonal Therapy 49 Xinlay 49 Preclinical Development 49 rPA Anthrax Vaccine 49 Ovarian Cancer Patients 49 #mg dosage strength 49 BIO Windhover 49 Anti Obesity 49 Chemotherapeutic Agents 49 Biomarkers 49 Ondansetron Orally Disintegrating Tablets 49 Velaglucerase Alfa 49 Acne Treatments 49 Veterinary Vaccines 49 sublingual tablets 49 Clinical Efficacy 49 Levofloxacin 49 Eisai Aricept 49 Viviant 49 Amrubicin 49 QbD 49 Human Monoclonal Antibodies 49 OvaRex R 49 Advanced Melanoma 49 Isotretinoin 49 Arranon 49 Whole Genome Sequencing 49 Patient Enrolment 49 Hsp# Inhibitor 49 Hatch Waxman 49 PREVU * 49 Relistor 49 Asmanex 49 Indaflex TM 49 PRIALT 49 PharmaMedDevice 48 RNA Therapeutics 48 Anticancer Activity 48 EpiCeram 48 IMS MIDAS